Блокада ренин-ангиотензиновой системы в профилактике и лечении диабетической ретинопатии: результаты исследования DIRECT
Блокада ренин-ангиотензиновой системы в профилактике и лечении диабетической ретинопатии: результаты исследования DIRECT
Шестакова М.В., Шамхалова М.Ш. Блокада ренин-ангиотензиновой системы в профилактике и лечении диабетической ретинопатии: результаты исследования DIRECT. Consilium Medicum. 2008; 10 (9): 9–11.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Список литературы
1. Дедов И.И., Шестакова М.В., Миленькая Т.М. Сахарный диабет: ретинопатия, нефропатия. Библиотека практикующего врача. М., 2001.
2. Batchelder T, Barricks M. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophtalmol 1995; 113: 702–5.
3. Chase HP, Garg SK, Jackson WE et al. Blood pressure and retinopathy in type 1 diabetes. Ophtalmology 1990; 97: 155–9.
4. Chaturvedi N, Sjolie AK, Stephenson JM et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID study group. EURODIAB Controlled Trial of Lisinopril in Insulin Dependent Diabetes Mellitus. Lancet 1998; 351: 28–31.
5. Estacio RO, Jeffers BW, Gifford N et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000; 23 (suppl. 2): B54–64.
6. Gillow JT, Gibson JM, Dodson PM. Hypertension and diabetic retinopathy – what's the story? Br J Ophtalmology 1999; 83: 1083–7.
7. Klein R, Klein BEK, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophtalmology 1998; 105: 1801–5.
8. Klein R, Moss SE, Klein BEK et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XI. The incidence of macular edema. Ophtalmology 1989; 96: 1501–10.
9. Moravski CJ, Skinner SL, Stubbs AJ et al. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies. Am J Pathol 2003; 162: 151–60.
10. Panja S, Sailesh S, Kohner EM et al. Retinal perfusion pressure: a clinical parameter predicting progression to sight-threatening diabetic retinopathy. 36th EASD Meeting, Jerusalem, Israel 2000.
11. Sjolie AK, Porta M, Parving HH et al. The DIabetic REtinopathy Candersantan Trials (DIRECT) Programme: baseline characteristics. JRAAS 2005; 6 (1): 25–32.
12. Sjolie AK. Prospects for angiotensin receptor blockers in diabetic retinopathy. Diab Res Clin Pract 2007; 76 (1): S31–S39.
13. Stratton IM, Kohner EM, Aldington SJ et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44: 156–63.
14. Sullivan PM, Davies EG, Galdwell G et al. Retinal blood flow during hyperglycaemia. Invest. Ophtalmol Vis Sci 1990; 31: 2041–5.
15. Testa MA, Puklin JE, Sherwin RS et al. Clinical predictors of retinopathy and its progression in patients with type 1 diabetes during CSII and conventional insulin treatment. Diabetes 1985; 34 (suppl. 3): 61–8.
16. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–13.
17. www DIRECT-results.org
2. Batchelder T, Barricks M. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophtalmol 1995; 113: 702–5.
3. Chase HP, Garg SK, Jackson WE et al. Blood pressure and retinopathy in type 1 diabetes. Ophtalmology 1990; 97: 155–9.
4. Chaturvedi N, Sjolie AK, Stephenson JM et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID study group. EURODIAB Controlled Trial of Lisinopril in Insulin Dependent Diabetes Mellitus. Lancet 1998; 351: 28–31.
5. Estacio RO, Jeffers BW, Gifford N et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000; 23 (suppl. 2): B54–64.
6. Gillow JT, Gibson JM, Dodson PM. Hypertension and diabetic retinopathy – what's the story? Br J Ophtalmology 1999; 83: 1083–7.
7. Klein R, Klein BEK, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophtalmology 1998; 105: 1801–5.
8. Klein R, Moss SE, Klein BEK et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XI. The incidence of macular edema. Ophtalmology 1989; 96: 1501–10.
9. Moravski CJ, Skinner SL, Stubbs AJ et al. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies. Am J Pathol 2003; 162: 151–60.
10. Panja S, Sailesh S, Kohner EM et al. Retinal perfusion pressure: a clinical parameter predicting progression to sight-threatening diabetic retinopathy. 36th EASD Meeting, Jerusalem, Israel 2000.
11. Sjolie AK, Porta M, Parving HH et al. The DIabetic REtinopathy Candersantan Trials (DIRECT) Programme: baseline characteristics. JRAAS 2005; 6 (1): 25–32.
12. Sjolie AK. Prospects for angiotensin receptor blockers in diabetic retinopathy. Diab Res Clin Pract 2007; 76 (1): S31–S39.
13. Stratton IM, Kohner EM, Aldington SJ et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44: 156–63.
14. Sullivan PM, Davies EG, Galdwell G et al. Retinal blood flow during hyperglycaemia. Invest. Ophtalmol Vis Sci 1990; 31: 2041–5.
15. Testa MA, Puklin JE, Sherwin RS et al. Clinical predictors of retinopathy and its progression in patients with type 1 diabetes during CSII and conventional insulin treatment. Diabetes 1985; 34 (suppl. 3): 61–8.
16. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–13.
17. www DIRECT-results.org
Авторы
М.В.Шестакова, М.Ш.Шамхалова
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.